Glory Health FY26 H1 net loss widens to RMB 272.08 million; revenue drops 56.95% to RMB 139.54 million

• Glory Health Industry posted a net loss attributable to shareholders of RMB 325.11 million, widening from RMB 225.18 million.
• Revenue fell 56.96% to RMB 139.54 million, driven by a drop in property development revenue to RMB 32.33 million.
• Basic loss per share widened to RMB 7.31 cents from RMB 5.07 cents.
• Contracted sales declined 41.6% to RMB 380.3 million, with Beijing contributing RMB 322.4 million.
• Management said it has suspended new investments, is accelerating asset disposals, and is negotiating repayment extensions for borrowings due before June 30, 2027.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Glory Health Industry Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260831-12309294), on August 31, 2026, and is solely responsible for the information contained therein.